India, April 27 -- Shares of Compass Therapeutics, Inc. (CMPX) tumbled sharply despite encouraging clinical results.
The stock is currently trading at $1.87, down $3.15 or 62.67%, on the Nasdaq. It opened at $1.76 after closing the previous session at $5.02. The stock has traded between $1.61 and $6.88 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....